COVID-19 Impact on Hives Treatment Market Competitive Strategies – LANNETT, WOCKHARDT, Amneal Pharmaceuticals LLC, Aurobindo Pharma

This Global Hives Treatment Market research report provides a complete overview of the market, taking into account different aspects of product definition, market segmentation based on different parameters and the established market landscape. The Hives Treatment Market research report also offers companies with a company profile, product specifications, production value, contact information of the manufacturer and company market shares. In addition, it combines all-inclusive industry analysis with specific estimates and forecasts to provide comprehensive research solutions with maximum clarity for strategic decision-making. Another important aspect of this market report is to think about the competitive landscape. The movements or actions of major market players and brands are therefore analyzed in the Hives Treatment Market report, which ranges from product development, launching of products, acquisitions, mergers, joint ventures and future products to technology.

Global Hives Treatment Market By Types (Acute Urticaria, Chronic Urticaria), Drugs (Antihistamines, H2 Antagonists, Tricyclic Antidepressants and Other),  Route of Administration (Oral, Topical and Others), End- Users (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Request for Sample Copy of this report @

Few of the major competitors currently working in the global Hives treatment market are Novartis AG, F. Hoffmann-La Roche Ltd, Elorac, GlaxoSmithKline PLC, CELLTRION INC, Teva Pharmaceutical Industries Ltd, LANNETT, WOCKHARDT, Amneal Pharmaceuticals LLC, Aurobindo Pharma,  Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Zydus Cadila, Dr. Reddy’s Laboratories Ltd, Torrent Pharmaceuticals Ltd, Breckenridge Pharmaceutical, Inc and others.

Market Analysis:

Global hives treatment market is expected to grow at a healthy CAGR in the forecast period of 2019-2026. Growing incidence ocular surface injuries as it can contribute to the neurotrophic keratitis and development of advanced therapies and treatment are the key factors for market growth

Market Definition:

Hives also known as urticaria is an inflammation of the skin that causes red, itchy, raised welts on the skin that appear in varying shapes and sizes either due to body body’s reaction to certain allergens or certain medication.

According to the statistics published by Novartis AG, it is estimated about 1.5 million people in the U.S. are affected by Chronic Idiopathic Urticaria (CIU). High demand of novel treatment and huge investment on research and development are drivers for market growth.

Market Drivers

  • Growing prevalence of urticaria worldwide is drive the market
  • Huge financial support to the researchers for developing novel intervention is boosting the market growth
  • High demand of disease specific novel treatment can also act as a market driver
  • Advancement in treatment and incorporation of novel formulation can improve the ease the pain of cold sores is also act as factors that drive the market

Market Restraints

  • Patent expiry of branded drugs and introduction of generics is also acting as a challenging factor for the growth of this market
  • Low healthcare budget in some developing countries is hamper the market growth

Table of Contents: Global Hives Treatment Market

Global Hives Treatment Market Research Report

Chapter 1 Global Hives Treatment Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis



By Strain Type

  • Acute Urticaria
  • Chronic Urticaria

By Drugs

  • Antihistamines
    • Cetirizine
    • Fexofenadine
    • Loratadine
    • Others
  • H2 Antagonists
    • Ranitidine
  • Tricyclic Antidepressants
    • Doxepin
    • Sulfonamide
  • Others

By Route of Administration

  • Oral
  • Topical
  • Others

By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America
    • US.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In July 2019, CELLTRION INC, initiated phase I trial of Omalizumab Biosimilar formally known as CT-P39 in the South Korea for the treatment of asthma and chronic idiopathic urticarial. If trial successful, it will improve the treatment landscape with cost effective for miilion of patients throughout the South korea.
  • In September 2018, Novartis AG in collaboration with F. Hoffmann-La Roche Ltd received approval from the FDA for Xolair (omalizumab), an immunoglobulin E blocker for the treatment of both allergic asthma and chronic idiopathic urticarial. It is available in 5 mg/0.5 mL and 150 mg/1 mL single-dose prefilled syringes with lyophilized, sterile powder for reconstitution. The approval of this drug provides a novel treatment and majao advances that offer complete heal of this condition

Competitive Analysis:

Global hives treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global hives treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

  • Current and future of global hives treatment market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Inquire for further detailed information before the purchase of this research report @

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]